VELCADE (Millennium Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the VELCADE drug offered from Millennium Pharmaceuticals, Inc.. This Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Millennium Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: bortezomib
SUBSTANCE NAME: BORTEZOMIB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-05-13
END MARKETING DATE: 0000-00-00


VELCADE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVELCADE from Millennium Pharmaceuticals, Inc.
LABELER NAME: Millennium Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3.5(mg/1)
START MARKETING DATE: 2003-05-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63020-049_a628369e-5225-47c4-8445-a674ea6fcb68
PRODUCT NDC: 63020-049
APPLICATION NUMBER: NDA021602

Other BORTEZOMIB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Millennium Pharmaceuticals, Inc.VELCADE